Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

Making polypharmacy safer for children with medical complexity.

Feinstein JA, Orth LE. Making polypharmacy safer for children with medical complexity. J Pediatr. 2023;254:4-10. 10.1016/j.jpeds.2022.10.012

Save
Print
April 5, 2023
Feinstein JA, Orth LE. J Pediatr. 2023;254:4-10.
View more articles from the same authors.

Children with medical complexity (CMC) frequently take multiple medications, often from multiple prescribers. This commentary describes the particular vulnerabilities CMC face throughout the medication use cycle, along with ways for the prescriber and system to mitigate the risks of polypharmacy.

Save
Print
Cite
Citation

Feinstein JA, Orth LE. Making polypharmacy safer for children with medical complexity. J Pediatr. 2023;254:4-10. 10.1016/j.jpeds.2022.10.012

Related Resources From the Same Author(s)
Related Resources